WT1 and desmoplastic small round cell tumor: Additionally, they performed WT1 ChIP-sequencing and established an shRNA knock-down model of EWSR1-WT1 in the JN-DSRCT-1 cell line and identified IGF2 and FGFR4 as potential therapeutic targets in DSRCT patients [13].